Opko Health, Inc. - Common Stock (OPK)
1.5100
0.00 (0.00%)
Opko Health Inc is a diversified healthcare company that focuses on developing and commercializing innovative healthcare solutions
The company operates in various segments, including diagnostics, pharmaceuticals, and biotechnology, aiming to enhance patient care and improve health outcomes. Through its portfolio of diagnostic tests, therapeutic products, and research initiatives, Opko Health strives to address unmet medical needs and contribute to advancements in precision medicine. With an emphasis on research and development, the company is dedicated to bringing novel treatments and diagnostics to market that can benefit patients across a range of health conditions.
3 Stocks That Wall Street Insiders Can’t Stop Buying
Insider trades are a telling indicator of C-Suite conviction but aren't always the signal for investors they could be. Only two of these stocks are good buys.
Via MarketBeat · December 30, 2024
Opko Health (OPK) Q3 2024 Earnings Call Transcriptfool.com
OPK earnings call for the period ending September 30, 2024.
Via The Motley Fool · November 7, 2024
Opko Health (OPK) Q2 2024 Earnings Call Transcriptfool.com
OPK earnings call for the period ending June 30, 2024.
Via The Motley Fool · August 8, 2024
Opko Health Stock Is Climbing: What's Going On?benzinga.com
Opko Health shares are trading higher Thursday after the company announced a $100 million share repurchase program. Here's a look at what to know:
Via Benzinga · July 18, 2024
Cintas Posts Upbeat Earnings, Joins CommScope Holding, Virtu Financial And Other Big Stocks Moving Higher On Thursdaybenzinga.com
Via Benzinga · July 18, 2024
Critical Insights From OPKO Health Analyst Ratings: What You Need To Knowbenzinga.com
Via Benzinga · April 1, 2024
Why Opko Health Shares Are Up After-Hoursbenzinga.com
Opko Health shares are trading higher after-hours Wednesday. The company announced it has entered into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx).
Via Benzinga · July 17, 2024
The 2024 Millionaire’s Club: 3 Penny Stocks to Buy Nowinvestorplace.com
One of the best ways to spot opportunity in penny stocks to buy is by following insiders. Here are three to consider.
Via InvestorPlace · May 31, 2024
Ondas Holdings And 2 Other Stocks Under $2 Insiders Are Buyingbenzinga.com
Via Benzinga · May 24, 2024
$3.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buyingbenzinga.com
Via Benzinga · May 20, 2024
Opko Health (OPK) Q1 2024 Earnings Call Transcriptfool.com
OPK earnings call for the period ending March 31, 2024.
Via The Motley Fool · May 7, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 8, 2024
Earnings Scheduled For February 27, 2024benzinga.com
Companies Reporting Before The Bell • Gaotu Techedu (NYSEGOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via Benzinga · February 27, 2024
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Via Benzinga · May 8, 2024
Flywire Reports Q1 Loss, Joins ZoomInfo, Inspire Medical Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 8, 2024
OPK Stock Earnings: OPKO Health Misses EPS, Misses Revenue for Q1 2024investorplace.com
OPK stock results show that OPKO Health missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 7, 2024
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com
Shares of Kodiak Sciences Inc. (NASDAQKOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.
Via Benzinga · March 28, 2024
Labcorp Expands Diagnostic Reach With Strategic Deal For Select Assets Of BioReference Healthbenzinga.com
Labcorp acquires certain operations of Opko Health subsidiary BioReference Health. The assets Labcorp is acquiring generate about $100 million in annual revenue, with the transaction valued at $237.5 million.
Via Benzinga · March 28, 2024
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursdaybenzinga.com
U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSEREX) rose sharply during Thursday’s session following upbeat quarterly earnings.
Via Benzinga · March 28, 2024
Immunic And 2 Other Stocks Under $2 Insiders Are Buyingbenzinga.com
The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · February 29, 2024
Opko Health (OPK) Q4 2023 Earnings Call Transcriptfool.com
OPK earnings call for the period ending December 31, 2023.
Via The Motley Fool · February 27, 2024
Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buyingbenzinga.com
The Dow Jones index closed higher by around 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · February 8, 2024